A Therapy Against National Barriers

Law360, New York (May 15, 2008, 12:00 AM EDT) -- In retrospect, the European pharmaceutical industry may well wonder why it owes the liberalization of advertising to a ginseng product. Ginseng is usually not the first ingredient that springs to mind when thinking of pharmaceutical products in Europe.

However, it's true that small causes can have great effects: what started out as just one of the hundreds of disputes initiated in Germany each year over pharmaceutical advertising triggered the most significant ruling on European pharmaceutical advertising to date, resulting in the creation of a uniform legal...
To view the full article, register now.